ConductScience.org, home

Paper41514979

Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts.

Sandybayeva SK and 4 others. Plants (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts. Papers, record 41514979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41514979

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts.
PubMed
Journal
Plants (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sandybayeva SKSandugash Khttps://orcid.org/0000-0002-4340-8749
2Ismailova SAShakhira Ahttps://orcid.org/0009-0007-3311-1267
3Yershova AOAnna O
4Kakimova ABArdak Bhttps://orcid.org/0000-0001-5612-1002
5Zayadan BKBolatkhan K

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AP22685516The Science Committee of the Ministry of Science and Higher Education of the Republic of KazakhstanPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132035961A thermophilic C-phycocyanin with unprecedented biophysical and biochemical properties.Int J Biol Macromol2020https://conductscience.org/library/papers/32035961PubMed
221468079Cyanobacteria: an emerging source for drug discovery.J Antibiot (Tokyo)2011https://conductscience.org/library/papers/21468079PubMed
333284578Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics.ACS Chem Neurosci2020https://conductscience.org/library/papers/33284578PubMed
439639093Immunomodulatory properties of polysaccharide extract samples from Cyanobacterium sp. Rippka B-1200.Sci Rep2024https://conductscience.org/library/papers/39639093PubMed
529403965Methods for in vitro evaluating antimicrobial activity: A review.J Pharm Anal2016https://conductscience.org/library/papers/29403965PubMed
611421730Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species.J Nat Prod2001https://conductscience.org/library/papers/11421730PubMed
740063398Characterization of Bioactive Metabolites in Phormidium sp. PB21: Pigment Production, Antimicrobial Potential, and Toxicity Assessment.Chem Biodivers2025https://conductscience.org/library/papers/40063398PubMed
835456747Cyanobacteria: Model Microorganisms and Beyond.Microorganisms2022https://conductscience.org/library/papers/35456747PubMed
926904724New Medium for Pharmaceutical Grade Arthrospira.Int J Bacteriol2013https://conductscience.org/library/papers/26904724PubMed
1031887317Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumours.Toxicon2020https://conductscience.org/library/papers/31887317PubMed
1137112036Phormidium ambiguum and Leptolyngbya ohadii Exopolysaccharides under Low Water Availability.Polymers (Basel)2023https://conductscience.org/library/papers/37112036PubMed
1219393308Biotechnological and industrial significance of cyanobacterial secondary metabolites.Biotechnol Adv2009https://conductscience.org/library/papers/19393308PubMed
139887530Hierridin B and 2,4-dimethoxy-6-heptadecyl-phenol, secondary metabolites from the cyanobacterium Phormidium ectocarpi with antiplasmodial activity.Phytochemistry1998https://conductscience.org/library/papers/9887530PubMed
1433036172The Chemistry, Biochemistry and Pharmacology of Marine Natural Products from Leptolyngbya, a Chemically Endowed Genus of Cyanobacteria.Mar Drugs2020https://conductscience.org/library/papers/33036172PubMed
1539519869Isolation, Identification and Pigment Analysis of Novel Cyanobacterial Strains from Thermal Springs.Plants (Basel)2024https://conductscience.org/library/papers/39519869PubMed
1632098255Carotenoids from Cyanobacteria: A Biotechnological Approach for the Topical Treatment of Psoriasis.Microorganisms2020https://conductscience.org/library/papers/32098255PubMed
1728073542The rise of toxic benthic Phormidium proliferations: A review of their taxonomy, distribution, toxin content and factors regulating prevalence and increased severity.Harmful Algae2016https://conductscience.org/library/papers/28073542PubMed
1836046667The survivor strain: isolation and characterization of Phormidium yuhuli AB48, a filamentous phototactic cyanobacterium with biotechnological potential.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36046667PubMed
1936836671Physiological and Biochemical Responses in Microalgae Dunaliella salina, Cylindrotheca closterium and Phormidium versicolor NCC466 Exposed to High Salinity and Irradiation.Life (Basel)2023https://conductscience.org/library/papers/36836671PubMed
2035265106Biosynthesis and Characterization of Silver Nanoparticles Produced by Phormidium ambiguum and Desertifilum tharense Cyanobacteria.Bioinorg Chem Appl2022https://conductscience.org/library/papers/35265106PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42635640Development of a Marine Algae-based Facial Cream Enriched With Phycoerythrin: Physicochemical Properties and Biological Activities.Mar Biotechnol (NY)2026https://conductscience.org/library/papers/42635640PubMed
41681662High-Purity Isolation of Polyphosphate-Rich Stabilisomes Defines Their Conserved Chemical Architecture in Thermophilic Cyanobacteria.Plants (Basel)2026https://conductscience.org/library/papers/41681662PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41514979

GET https://conductscience.org/api/papers/v1/41514979/references?page=2